Tokyo Tape
Sign in
← Alfresa Holdings

Quarterly report · Q3

2784.TEDINET S100Q7GQ
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥2.05T2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥2.59T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.97T2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥20.0bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥18.7bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥22.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥32.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥21.5bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥22.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥27.6bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥14.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥32.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥18.7bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥14.9bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥18.8bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥1.44Tat 2022-12-31Cons.Assets
Total assets¥1.30Tat 2022-03-31Cons.Assets
Total assets¥1.39Tat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥956.8bnat 2022-12-31Cons.Liabilities
Total liabilities¥832.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥481.9bnat 2022-12-31Cons.Net assets
Net assets / equity¥471.8bnat 2022-03-31Cons.Net assets
Net assets / equity¥477.8bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥192.9bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥180.4bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥73.242022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.642022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥153.572021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.782021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥55.942021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio33.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio36.2%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 45
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥24.1bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥24.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31¥372m
jpcrp040300-q3r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.82T
jpcrp040300-q3r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.81T
jpcrp040300-q3r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥13.1bn
jpcrp040300-q3r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥16.9bn
jpcrp040300-q3r_E02962-000Manufacturing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥36.4bn
jpcrp040300-q3r_E02962-000Manufacturing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥25.8bn
jpcrp040300-q3r_E02962-000Manufacturing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥10.6bn
jpcrp040300-q3r_E02962-000Manufacturing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥992m
jpcrp040300-q3r_E02962-000Medical Related Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥27.1bn
jpcrp040300-q3r_E02962-000Medical Related Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥27.1bn
jpcrp040300-q3r_E02962-000Medical Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥0
jpcrp040300-q3r_E02962-000Medical Related Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥43m
jpcrp040300-q3r_E02962-000Self Medication Products Wholesaling Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥186.8bn
jpcrp040300-q3r_E02962-000Self Medication Products Wholesaling Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥186.3bn
jpcrp040300-q3r_E02962-000Self Medication Products Wholesaling Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥429m
jpcrp040300-q3r_E02962-000Self Medication Products Wholesaling Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥2.07T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥2.05T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥24.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥19.6bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥22.1bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥22.1bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31¥325m
jpcrp040300-q3r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥1.74T
jpcrp040300-q3r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥1.73T
jpcrp040300-q3r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥12.6bn
jpcrp040300-q3r_E02962-000Ethical Pharmaceuticals Wholesaling Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥15.8bn
jpcrp040300-q3r_E02962-000Manufacturing Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥34.8bn
jpcrp040300-q3r_E02962-000Manufacturing Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥25.7bn
jpcrp040300-q3r_E02962-000Manufacturing Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥9.1bn
jpcrp040300-q3r_E02962-000Manufacturing Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥1.4bn
jpcrp040300-q3r_E02962-000Medical Related Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥25.7bn
jpcrp040300-q3r_E02962-000Medical Related Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥25.7bn
jpcrp040300-q3r_E02962-000Medical Related Businessreportable segmentsegment profit2021-04-01 → 2021-12-31−¥304m
jpcrp040300-q3r_E02962-000Self Medication Products Wholesaling Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥189.0bn
jpcrp040300-q3r_E02962-000Self Medication Products Wholesaling Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥188.5bn
jpcrp040300-q3r_E02962-000Self Medication Products Wholesaling Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥467m
jpcrp040300-q3r_E02962-000Self Medication Products Wholesaling Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥1.99T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥1.97T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥22.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥18.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 383
ItemContextValueUnit
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member317300
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0016
Number of shares held in own name treasury shares etcCurrentQuarterInstant317300
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant317300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0016
Cash and depositsPrior1YearInstant180436000000JPY
Cash and depositsCurrentQuarterInstant192851000000JPY
Notes and accounts receivable tradePrior1YearInstant602488000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant675740000000JPY
Merchandise and finished goodsPrior1YearInstant140156000000JPY
Merchandise and finished goodsCurrentQuarterInstant164277000000JPY
Work in processPrior1YearInstant1294000000JPY
Work in processCurrentQuarterInstant1652000000JPY
Raw materials and suppliesPrior1YearInstant5439000000JPY
Raw materials and suppliesCurrentQuarterInstant6390000000JPY
Other caPrior1YearInstant88908000000JPY
Other caCurrentQuarterInstant94821000000JPY
Allowance for doubtful accounts caPrior1YearInstant-2252000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-2023000000JPY
Current assetsPrior1YearInstant1016471000000JPY
Current assetsCurrentQuarterInstant1133711000000JPY
Buildings and structures netPrior1YearInstant63708000000JPY
Buildings and structures netCurrentQuarterInstant65181000000JPY
LandPrior1YearInstant70018000000JPY
LandCurrentQuarterInstant72174000000JPY
Other net ppePrior1YearInstant29031000000JPY
Other net ppeCurrentQuarterInstant34928000000JPY
Property plant and equipmentPrior1YearInstant162758000000JPY
Property plant and equipmentCurrentQuarterInstant172285000000JPY
GoodwillPrior1YearInstant2913000000JPY
GoodwillCurrentQuarterInstant2668000000JPY
Other iaPrior1YearInstant15894000000JPY
Other iaCurrentQuarterInstant15071000000JPY
Intangible assetsPrior1YearInstant18807000000JPY
Intangible assetsCurrentQuarterInstant17739000000JPY
Investment securitiesPrior1YearInstant87284000000JPY
Investment securitiesCurrentQuarterInstant96361000000JPY
Other ioaPrior1YearInstant22444000000JPY
Other ioaCurrentQuarterInstant23810000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-3774000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-5213000000JPY
Investments and other assetsPrior1YearInstant105954000000JPY
Investments and other assetsCurrentQuarterInstant114957000000JPY
Noncurrent assetsPrior1YearInstant287520000000JPY
Noncurrent assetsCurrentQuarterInstant304981000000JPY
AssetsPrior1YearInstant1303991000000JPY
AssetsCurrentQuarterInstant1438692000000JPY
Notes and accounts payable tradePrior1YearInstant755250000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass